Asymmetric synthesis of a selective endothelin A receptor antagonist.

Chem Pharm Bull (Tokyo)

Process Research, Process R&D, Laboratories for Technology Development, Banyu Pharmaceutical Co., Ltd, Aichi, Japan.

Published: August 2002

An asymmetric synthesis of a selective endothelin A receptor antagonist 1b is described. Asymmetric conjugate addition of aryllithium derived from 18 to the chiral oxazoline 17 followed by hydrolysis afforded 15 in 96% ee via purification as (S)-(-)-1-phenylethylamine salt. Pd(OAc)(2)/dppf (1,1'-bis(diphenylphosphino)ferrocene) catalyzed carbonylation followed by chemoselective addition of aryllithium derived from 23 which gave ketone 24. Diastereoselective reduction of the ketone with catecholborane followed by concomitant activation of the resulting alcohol and cyclization gave the late intermediate 26. Introduction of amino moiety on the pyridine ring by imidoyl rearrangement followed by deprotection and purification by crystallization furnished the enantiomerically pure target molecule 1b in 8% overall yield from 16.

Download full-text PDF

Source
http://dx.doi.org/10.1248/cpb.50.1066DOI Listing

Publication Analysis

Top Keywords

asymmetric synthesis
8
synthesis selective
8
selective endothelin
8
endothelin receptor
8
receptor antagonist
8
addition aryllithium
8
aryllithium derived
8
antagonist asymmetric
4
antagonist described
4
described asymmetric
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!